The global spinal muscular atrophy (SMA) treatment market size was valued at USD 2.22 billion in 2022 and is poised to grow at a significant CAGR of 28.9% during the forecast period 2023-29. It also includes market size and projection estimations for each of the five major regions from 2023 to 2029. The research report includes historical data, trending features, and market growth estimates for the future. Furthermore, the study includes a global and regional estimation and further split by nations and categories within each region. The research also includes factors and barriers to the spinal muscular atrophy (SMA) treatment market growth, as well as their impact on the market's future growth. The report gives a comprehensive overview of both primary and secondary data.